CA2884331C - Human sebum mimetics derived from botanical sources and methods for making the same - Google Patents
Human sebum mimetics derived from botanical sources and methods for making the same Download PDFInfo
- Publication number
- CA2884331C CA2884331C CA2884331A CA2884331A CA2884331C CA 2884331 C CA2884331 C CA 2884331C CA 2884331 A CA2884331 A CA 2884331A CA 2884331 A CA2884331 A CA 2884331A CA 2884331 C CA2884331 C CA 2884331C
- Authority
- CA
- Canada
- Prior art keywords
- human sebum
- mimetic composition
- sebum mimetic
- human
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000002374 sebum Anatomy 0.000 title claims abstract description 130
- 238000000034 method Methods 0.000 title abstract description 10
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 claims abstract description 58
- 235000021319 Palmitoleic acid Nutrition 0.000 claims abstract description 29
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 claims abstract description 29
- 229940119170 jojoba wax Drugs 0.000 claims abstract description 24
- 239000003921 oil Substances 0.000 claims abstract description 24
- 235000019198 oils Nutrition 0.000 claims abstract description 24
- 235000019493 Macadamia oil Nutrition 0.000 claims abstract description 21
- 239000010469 macadamia oil Substances 0.000 claims abstract description 21
- 239000004164 Wax ester Substances 0.000 claims abstract description 18
- 235000019386 wax ester Nutrition 0.000 claims abstract description 18
- 238000009884 interesterification Methods 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims description 69
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 32
- 239000000470 constituent Substances 0.000 claims description 25
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 19
- 150000002632 lipids Chemical class 0.000 claims description 18
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 15
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 15
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 15
- 239000005642 Oleic acid Substances 0.000 claims description 15
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 15
- 235000021314 Palmitic acid Nutrition 0.000 claims description 15
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 15
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 15
- 210000000434 stratum corneum Anatomy 0.000 claims description 14
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 12
- 210000003491 skin Anatomy 0.000 claims description 11
- 210000002615 epidermis Anatomy 0.000 claims description 10
- 239000006210 lotion Substances 0.000 claims description 10
- 229940106189 ceramide Drugs 0.000 claims description 8
- 150000003408 sphingolipids Chemical class 0.000 claims description 8
- 229930003799 tocopherol Natural products 0.000 claims description 7
- 239000011732 tocopherol Substances 0.000 claims description 7
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 6
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 6
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 6
- 235000012000 cholesterol Nutrition 0.000 claims description 6
- 230000003750 conditioning effect Effects 0.000 claims description 6
- 239000003205 fragrance Substances 0.000 claims description 6
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 6
- BHYOQNUELFTYRT-UHFFFAOYSA-N Cholesterol sulfate Natural products C1C=C2CC(OS(O)(=O)=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 BHYOQNUELFTYRT-UHFFFAOYSA-N 0.000 claims description 5
- BHYOQNUELFTYRT-DPAQBDIFSA-N cholesterol sulfate Chemical compound C1C=C2C[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 BHYOQNUELFTYRT-DPAQBDIFSA-N 0.000 claims description 5
- 239000013538 functional additive Substances 0.000 claims description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 5
- 239000011707 mineral Substances 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 4
- 239000003963 antioxidant agent Substances 0.000 claims description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- 229960001295 tocopherol Drugs 0.000 claims description 4
- 235000010384 tocopherol Nutrition 0.000 claims description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- 239000004909 Moisturizer Substances 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 239000003974 emollient agent Substances 0.000 claims description 3
- 230000001333 moisturizer Effects 0.000 claims description 3
- 239000000049 pigment Substances 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 239000004615 ingredient Substances 0.000 description 11
- 229940098695 palmitic acid Drugs 0.000 description 11
- 150000004665 fatty acids Chemical group 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- NNNVXFKZMRGJPM-KHPPLWFESA-N sapienic acid Chemical compound CCCCCCCCC\C=C/CCCCC(O)=O NNNVXFKZMRGJPM-KHPPLWFESA-N 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 229940068065 phytosterols Drugs 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 4
- 241000221095 Simmondsia Species 0.000 description 4
- 235000004433 Simmondsia californica Nutrition 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000021588 free fatty acids Nutrition 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 125000002640 tocopherol group Chemical class 0.000 description 3
- 235000019149 tocopherols Nutrition 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 238000004061 bleaching Methods 0.000 description 2
- 150000001783 ceramides Chemical class 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229940101267 panthenol Drugs 0.000 description 2
- 235000020957 pantothenol Nutrition 0.000 description 2
- 239000011619 pantothenol Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 2
- 229950011392 sorbitan stearate Drugs 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- -1 sterol esters Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- CFOQKXQWGLAKSK-KTKRTIGZSA-N (13Z)-docosen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCO CFOQKXQWGLAKSK-KTKRTIGZSA-N 0.000 description 1
- GWHCXVQVJPWHRF-KTKRTIGZSA-N (15Z)-tetracosenoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-KTKRTIGZSA-N 0.000 description 1
- DJCQJZKZUCHHAL-UHFFFAOYSA-N (Z)-9-Pentadecensaeure Natural products CCCCCC=CCCCCCCCC(O)=O DJCQJZKZUCHHAL-UHFFFAOYSA-N 0.000 description 1
- OJQMPIICCPYCQQ-KTKRTIGZSA-N (z)-tetracos-15-en-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCCCO OJQMPIICCPYCQQ-KTKRTIGZSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- 241000596117 Alophia Species 0.000 description 1
- 241001071161 Asclepias Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010064729 Dark circles under eyes Diseases 0.000 description 1
- 206010012444 Dermatitis diaper Diseases 0.000 description 1
- 208000003105 Diaper Rash Diseases 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- 101100291369 Mus musculus Mip gene Proteins 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- XJXROGWVRIJYMO-SJDLZYGOSA-N Nervonic acid Natural products O=C(O)[C@@H](/C=C/CCCCCCCC)CCCCCCCCCCCC XJXROGWVRIJYMO-SJDLZYGOSA-N 0.000 description 1
- 101150116466 PALM gene Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 206010040954 Skin wrinkling Diseases 0.000 description 1
- 241000534509 Telopea Species 0.000 description 1
- 241000736893 Thunbergia Species 0.000 description 1
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 description 1
- QYMBNBIOVWFSQC-UHFFFAOYSA-N [C].NO Chemical group [C].NO QYMBNBIOVWFSQC-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 230000003822 cell turnover Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 description 1
- UWHZIFQPPBDJPM-FPLPWBNLSA-N cis-vaccenic acid Chemical compound CCCCCC\C=C/CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-FPLPWBNLSA-N 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229940071160 cocoate Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- BITHHVVYSMSWAG-UHFFFAOYSA-N eicosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCC(O)=O BITHHVVYSMSWAG-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 1
- 229940093504 ethyl macadamiate Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940057874 phenyl trimethicone Drugs 0.000 description 1
- 239000003016 pheromone Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 235000003784 poor nutrition Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 150000003410 sphingosines Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Human sebum mimetics and methods for producing human sebum mimetics are provided. In one exemplary embodiment, a human sebum mimetic comprises a wax ester derived from interesterification of refined botanical oil comprising palmitoleic acid and refined jojoba oil, a phytosterol, phytosqualene, and/or phytosteryl macadamiate. Method for producing a human sebum mimetic comprises mixing refined macadamia oil and refined jojoba oil, interesterifying the refined macadamia oil and the refined jojoba oil, adding a phytosterol, adding phytosteryl macadamiate, and adding phytosqualene after the interesterifying.
Description
HUMAN SEBUM MIMETICS DERIVED FROM BOTANICAL
SOURCES AND METHODS FOR MAKING THE SAME
TECHNICAL FIELD
[0001] The present invention generally relates to personal care compositions and methods for manufacturing them, and more particularly relates to human sebum mimetics derived from botanical sources and methods for making them.
BACKGROUND
SOURCES AND METHODS FOR MAKING THE SAME
TECHNICAL FIELD
[0001] The present invention generally relates to personal care compositions and methods for manufacturing them, and more particularly relates to human sebum mimetics derived from botanical sources and methods for making them.
BACKGROUND
[0002] Human sebum is secreted by the sebaceous glands that are found over substantially the entire skin surface (except the palms of the hands and soles of the feet), but are found predominately on the scalp, face, chest, and back.
Sebum is involved in development of the epidermal structure and maintenance of the epidermal permeability barrier, carrying anti-oxidants to the skin surface, protecting the skin from microbial colonization, generating body odor, and producing pheromones.
Sebum is involved in development of the epidermal structure and maintenance of the epidermal permeability barrier, carrying anti-oxidants to the skin surface, protecting the skin from microbial colonization, generating body odor, and producing pheromones.
[0003] When secreted, human sebum is a complex mixture of triglycerides, wax esters, sterol esters, cholesterol, cholesterol esters, and squalene. As the sebum is secreted, it consists primarily of triglycerides and wax esters, which are broken down by commensal microbes into diglycerides, monoglycerides, and the constituent free fatty acids. The fatty acid chain lengths of human sebum vary considerably, but have predominantly 16 and 18 carbons, such as in the case of stearic acid (18 carbons with no double bond (hereinafter denoted Cl 8:0)), oleic acid (C18:1 with one double bond on the ninth carbon (hereinafter denoted C18:1 9)), linoleic acid (C18:2 9 12), palmitic acid (C16:0), and sapienic acid (16:1 6).
[0004] Loss of human sebum can be due to a variety of environmental factors such as bathing, weather conditions, chemical products, and poor nutrition, and also can be due to genetics. For example, a natural lack of sebum is observed on the scalp of African-Americans. A loss of sebum can result in itching, dandruff, wrinkles, diaper rash and the like on the skin. In addition, the hair may become brittle and dry without a sufficient amount of sebum to moisturize it. While a variety of products exist that attempt to repair the suppleness caused by lack of sebum, many of these products contain synthetic components or components that are derived from animals and do not mimic the structure and formulation of human sebum. In this regard, the products are not absorbed by the skin as readily as human sebum. In addition, the products are often made from unstable ingredients that exhibit a short shelf life.
[0005] Accordingly, it is desirable to provide a human sebum mimetic. In addition, it is desirable to provide a human sebum mimetic produced from plant sources. It is also desirable to provide a method for manufacturing a human sebum mimetic. Furthermore, other desirable features and characteristics of the present invention will become apparent from the subsequent detailed description of the invention and the appended claims, taken in conjunction with this background of the invention.
BRIEF SUMMARY
BRIEF SUMMARY
[0006] Human sebum mimetics and methods for producing human sebum mimetics are provided. In one exemplary embodiment, a human sebum mimetic may comprise a wax ester derived from interesterification of a refined botanical oil comprising palmitoleic acid and refined jojoba oil, a phytosterol, and phytosqualene.
[00071 In another exemplary embodiment, a method for producing a human sebum mimetic may comprise mixing refined macadamia oil and refined jojoba oil, interesterifying the refined macadamia oil and the refined jojoba oil, adding a phytosterol before or after the interesterifying, and adding phytosqualene after the interesterifying.
[0008] In a further exemplary embodiment, a human sebum mimetic m ay comprise a wax ester comprising a fatty acid having 16 carbons and one double bond and that is derived from a plant source, a phytosterol, and phytosqualene.
[0009] In a further exemplary embodiment, a human sebum mimetic may comprise a wax ester derived from interesterification of a refined botanical oil comprising palmitoleic acid and refined jojoba oil, a phytosterol, phytosqualene, and phytosteryl macadamiate.
[0010] In accordance with an aspect of at least one embodiment, there is provided a human sebum mimetic composition comprising: a wax ester derived from interesterification of: a refined jojoba oil; and a refined botanical oil comprising palmitoleic acid; a phytosterol; phytosqualene; phytosteryl macadamiate; and a constituent lipid of a stratum corneum layer of an epidermis.
[0011] In accordance with an aspect of at least one embodiment, there is provided a human sebum mimetic composition comprising: a wax ester comprising a fatty acid having 16 carbons and one double bond and that is derived from a plant source; a phytosterol; phytosqualene; phytosteryl macadamiate; and a constituent of a stratum corneum layer of an epidermis.
[0012] In accordance with an aspect of at least one embodiment, there is provided a human sebum mimetic composition comprising: a wax ester derived from interesterification of: refined jojoba oil; and an oil comprising a triglyceride and palm itoleic acid; a phytosterol; phytosqualene; phytosteryl macadamiate; and a constituent lipid of a stratum corneum layer of an epidermis.
DETAILED DESCRIPTION
[0013] The following detailed description is merely exemplary in nature and is not intended to limit the invention or the application and uses of the invention. Furthermore, there is no intention to be bound by any theory presented in the preceding background or the following detailed description.
[0014] Various embodiments contemplated herein are directed to compositions that mimic human sebum. The approximate composition of human sebum includes by weight percent (wt.%) (from Pierre Agache, "Sebaceous Physiology,"
Measuring The Skin, Springer-Verlog, 2004, pp. 271-280):
Squalene 12 wt.%
Wax esters 26 wt.%
Glycerides and free fatty acids 57.5 wt.%
Sterols (free and esters) 4.5 wt.%
The human sebum mimetics contemplated herein are plant based, that is, the components of the mimetics are derived either physically or chemically from plant sources. In this regard, the mimetics are plant-derived analogs of human sebum in that they are derived from phytosqualene, phytosterols, a refined botanical oil such as macadamia oil, which is the source of the mimetics's triglycerides, and refined jojoba oil, which is the source of the mimetics' wax esters. As used herein, the term "refined oil" means crude oil that has had undesirable compounds such as free fatty acids, carbohydrates, metals, proteins, and the like removed using caustic agents, washing, and centrifugation. In one embodiment, the human sebum mimetic is derived from phytosqualene in an amount of about 5 to about 20 wt.% of the entire mimetic, refined jojoba oil in an amount of about 20 to about 35 wt.% of the entire mimetic, refined macadamia oil in an amount of about 45 to about 65 wt.% of the entire mimetic, and phytosterols in an amount of about 0.5 to about 10 wt.% of the entire mimetic. In a preferred embodiment, the human sebum mimetic is derived from phytosqualene in an amount of about II to about 15 wt.% of the entire mimetic, refinedjojoba oil in an amount of about 29 to about 33 wt.% of the entire mimetic, refined macadamia oil in an amount of about 51 to about 55 wt.% of the entire mimetic, and phytosterols in an amount of about 1 to about 5 wt.% of the entire mimetic. In a more preferred embodiment, the human sebum mimetic is derived from the following composition in weight percent:
Phytosqualene 12.9 wt.%
Refined jojoba oil 30.8 wt.%
Refined macadamia oil 53.2 wt.%
Phytosterols 3.1 wt.%
[0015] Of its fatty acids, human sebum has particularly high levels of palmitic acid (16:0), sapienic acid (16:1 6), and oleic acid (C18:1 9). Analogously, the human sebum mimetics contemplated herein also comprise high levels of palm itic acid and oleic acid, as macadamia oil itself comprises about 8.8 wt.% palmitic acid and about 58 w t. % oleic acid. In one embodiment, the human sebum mimetic comprises about 1 to about 10 wt.% palmitic acid, in a preferred embodiment about 3 to about 7 wt.% palmitic acid, and in a more preferred embodiment about 4.8 wt.% palmitic acid. In another embodiment, the human sebum comprises about 25 to about 35 wt.% oleic acid, in a preferred embodiment about 30 to about 34 wt.% oleic acid, and in a more preferred embodiment about 31.6 wt.% oleic acid.
[0016] However. sapienic acid is unique among mammals. Palmitoleic acid (16:
1 9), an analog of sapienic acid, is a substitute for the sapienic acid. While palmitoleic acid is fairly rare in the plant kingdom, macadamia oil has the highest palmitoleic acid content of the currently-available commercial oils, with about 16-22% palmitoleic acid. Accordingly, the inventors have found that by interesterifying the refined macadamia oil and the refined jojoba oil of the human sebum mimetic, a wax ester comprising palmitoleic acid results. While macadamia oil is preferred, other seed oils contain greater than 10% palmitoleic acid and also may be interesterified with refined jojoba oil to produce a wax ester comprising palmitoleic acid. The genera of these species include Thunbergia, Doxantha, Alophia, Roureopsis, Telopea, and Asclepias.
[0017] In one embodiment, the human sebum mimetic comprises palmitoleic acid in an amount of about 5 to about 15 wt.% of the entire mimetic composition.
In a preferred embodiment, the human sebum mimetic comprises palm itoleic acid in an amount of about 8 to about 12 wt.% of the entire mimetic composition and, in a more preferred embodiment, the human sebum mimetic comprises palmitoleic acid in an amount of about 9.7 wt.% of the entire mimetic composition. In a most preferred embodiment, the human sebum mimetic comprises the following fatty acids and fatty alcohols in weight percent:
Fatty acids: Wt. % Fatty Alcohols Wt. %
Myristic acid (14:0) 0.5 cis-11-Eicosenaol (20:1) 5.9 Palmitic acid (16:0) 4.8 cis-13-docosenol (22:1) 6.3 Palm itoleic acid (16: I ) 9.7 cis-15-tetracosenol (24:1) 1.9 Stearic acid (18:0) 1.9 Unknown 18:1 (18:1) 0.1 Oleic acid (18:1) 31.6 cis-Vaccenic acid (18:1) 1.6 Linoleic acid (18:2) 1.3 Linolenic acid (18:3) 0.1 Arachidic acid (20:0) 1.5 cis-11-Eicosenoic acid (20:1) 13.9 Behenic acid (22:0) 0.5 Erucic acid (22:1) 2.9 Lignoceric acid (24:0) 0.2 Nervonic acid (24:1) 0.3.
[0018] In another exemplary embodiment, the human sebum mimetic may comprise the compositional lipid profile of the sebum of any selected profile, such as an exemplary 22 year old human female. The human sebum mimetic may be derived from interesterifying refined jojoba oil in an amount of about 24.9 wt.% of the entire mimetic and a refined botanical oil comprising palm itolcic acid in an amount of about 61.9 wt.% of the entire mimetic. In one embodiment, the refined botanical oil comprising palmitoleic acid may comprise refined macadamia oil. The mimetic may further comprise phytosqualene in an amount of about 12.6 wt.% of the entire mimetic, phytosterols in an amount of about 0.4 wt.%
of the entire mimetic, phytosteryl macadam iatc in an amount of about 0.1 wt.% of the entire mimetic, and/or tocopherols in an amount of about 0.1 wt.%
of the entire mimetic (about 1000 parts per million).
[0019] In various embodiments of the present invention, the human sebum mimetic may further comprise an effective amount of any constituent lipid found in a stratum corneum layer of an epidermis. In one embodiment, the human sebum mimetic may comprise a derivative and/or precursor of the constituent lipid. In one embodiment, the constituent lipid may be present in the human sebum mimetic in an effective amount to organize the intercellular lamellar lipid structure of the stratum corneum to at least partially promote and/or maintain the water permeability barrier function of the skin.
For example, in one embodiment, the constituent lipid may comprise fatty acids such as long chain saturated fatty acid having chains lengths of C16 to C30 and/or unsaturated fatty acids such as linoleate. In another embodiment, the constituent lipid may comprise a sphingolipid and/or a ceramide. Sphingolipids may comprise any one or more of the structurally heterogeneous family of lipids. For example, the sphingolipids may have eighteen carbon amino-alcohol backbones that may be called sphingoid bases. In one embodiment, the mimetic may comprise the sphingolipid in an amount up to about 27 wt.% of the entire mimetic. Ceramides may comprise a structurally heterogeneous family of sphingolipid base derivatives with amide linkages to a variety of long-chain fatty acids. For example, the ceramide may comprise any one or more ceramides found in human stratum corneum, such as acylceramides. In one embodiment, the mimetic may comprise the ceramide in an amount up to about 27 wt.%
of the entire mimetic.
[0020] In various embodiments of the present invention, any human sebum mimetic may further comprise an effective amount of trace constituents of the stratum corneum layer of an epidermis. For example, in one embodiment, the trace constituent may comprise cholesterol such as cholesterol sulfate. In some embodiments, the cholesterol sulfate may be comprise a portion of a human sebum mimetic in an amount similar to the amount of cholesterol sulfate found in a stratum corneum, such as up to about 2 to about wt.% of the entire mimetic. In another embodiment, the trace constituent may be a mineral such as calcium (Ca2+). In some embodiments, the mimetic may comprise the trace constituent in an amount up to about 12 wt.% of the entire mimetic.
[0021] In another exemplary embodiment, the human sebum mimetics contemplated herein comprise additional functional additives, that is, an ingredient added to perform a particular function. For example, the human sebum mimetics may comprise tocopherols. In one embodiment, the human sebum mimetic comprises about 100 to about 2000 parts per million (ppm) of 70%
tocopherols, preferably about 1430 ppm. The human sebum mimetics may also comprise fragrances, dyes, pigments, preservatives, antioxidants, moisturizers,
[00071 In another exemplary embodiment, a method for producing a human sebum mimetic may comprise mixing refined macadamia oil and refined jojoba oil, interesterifying the refined macadamia oil and the refined jojoba oil, adding a phytosterol before or after the interesterifying, and adding phytosqualene after the interesterifying.
[0008] In a further exemplary embodiment, a human sebum mimetic m ay comprise a wax ester comprising a fatty acid having 16 carbons and one double bond and that is derived from a plant source, a phytosterol, and phytosqualene.
[0009] In a further exemplary embodiment, a human sebum mimetic may comprise a wax ester derived from interesterification of a refined botanical oil comprising palmitoleic acid and refined jojoba oil, a phytosterol, phytosqualene, and phytosteryl macadamiate.
[0010] In accordance with an aspect of at least one embodiment, there is provided a human sebum mimetic composition comprising: a wax ester derived from interesterification of: a refined jojoba oil; and a refined botanical oil comprising palmitoleic acid; a phytosterol; phytosqualene; phytosteryl macadamiate; and a constituent lipid of a stratum corneum layer of an epidermis.
[0011] In accordance with an aspect of at least one embodiment, there is provided a human sebum mimetic composition comprising: a wax ester comprising a fatty acid having 16 carbons and one double bond and that is derived from a plant source; a phytosterol; phytosqualene; phytosteryl macadamiate; and a constituent of a stratum corneum layer of an epidermis.
[0012] In accordance with an aspect of at least one embodiment, there is provided a human sebum mimetic composition comprising: a wax ester derived from interesterification of: refined jojoba oil; and an oil comprising a triglyceride and palm itoleic acid; a phytosterol; phytosqualene; phytosteryl macadamiate; and a constituent lipid of a stratum corneum layer of an epidermis.
DETAILED DESCRIPTION
[0013] The following detailed description is merely exemplary in nature and is not intended to limit the invention or the application and uses of the invention. Furthermore, there is no intention to be bound by any theory presented in the preceding background or the following detailed description.
[0014] Various embodiments contemplated herein are directed to compositions that mimic human sebum. The approximate composition of human sebum includes by weight percent (wt.%) (from Pierre Agache, "Sebaceous Physiology,"
Measuring The Skin, Springer-Verlog, 2004, pp. 271-280):
Squalene 12 wt.%
Wax esters 26 wt.%
Glycerides and free fatty acids 57.5 wt.%
Sterols (free and esters) 4.5 wt.%
The human sebum mimetics contemplated herein are plant based, that is, the components of the mimetics are derived either physically or chemically from plant sources. In this regard, the mimetics are plant-derived analogs of human sebum in that they are derived from phytosqualene, phytosterols, a refined botanical oil such as macadamia oil, which is the source of the mimetics's triglycerides, and refined jojoba oil, which is the source of the mimetics' wax esters. As used herein, the term "refined oil" means crude oil that has had undesirable compounds such as free fatty acids, carbohydrates, metals, proteins, and the like removed using caustic agents, washing, and centrifugation. In one embodiment, the human sebum mimetic is derived from phytosqualene in an amount of about 5 to about 20 wt.% of the entire mimetic, refined jojoba oil in an amount of about 20 to about 35 wt.% of the entire mimetic, refined macadamia oil in an amount of about 45 to about 65 wt.% of the entire mimetic, and phytosterols in an amount of about 0.5 to about 10 wt.% of the entire mimetic. In a preferred embodiment, the human sebum mimetic is derived from phytosqualene in an amount of about II to about 15 wt.% of the entire mimetic, refinedjojoba oil in an amount of about 29 to about 33 wt.% of the entire mimetic, refined macadamia oil in an amount of about 51 to about 55 wt.% of the entire mimetic, and phytosterols in an amount of about 1 to about 5 wt.% of the entire mimetic. In a more preferred embodiment, the human sebum mimetic is derived from the following composition in weight percent:
Phytosqualene 12.9 wt.%
Refined jojoba oil 30.8 wt.%
Refined macadamia oil 53.2 wt.%
Phytosterols 3.1 wt.%
[0015] Of its fatty acids, human sebum has particularly high levels of palmitic acid (16:0), sapienic acid (16:1 6), and oleic acid (C18:1 9). Analogously, the human sebum mimetics contemplated herein also comprise high levels of palm itic acid and oleic acid, as macadamia oil itself comprises about 8.8 wt.% palmitic acid and about 58 w t. % oleic acid. In one embodiment, the human sebum mimetic comprises about 1 to about 10 wt.% palmitic acid, in a preferred embodiment about 3 to about 7 wt.% palmitic acid, and in a more preferred embodiment about 4.8 wt.% palmitic acid. In another embodiment, the human sebum comprises about 25 to about 35 wt.% oleic acid, in a preferred embodiment about 30 to about 34 wt.% oleic acid, and in a more preferred embodiment about 31.6 wt.% oleic acid.
[0016] However. sapienic acid is unique among mammals. Palmitoleic acid (16:
1 9), an analog of sapienic acid, is a substitute for the sapienic acid. While palmitoleic acid is fairly rare in the plant kingdom, macadamia oil has the highest palmitoleic acid content of the currently-available commercial oils, with about 16-22% palmitoleic acid. Accordingly, the inventors have found that by interesterifying the refined macadamia oil and the refined jojoba oil of the human sebum mimetic, a wax ester comprising palmitoleic acid results. While macadamia oil is preferred, other seed oils contain greater than 10% palmitoleic acid and also may be interesterified with refined jojoba oil to produce a wax ester comprising palmitoleic acid. The genera of these species include Thunbergia, Doxantha, Alophia, Roureopsis, Telopea, and Asclepias.
[0017] In one embodiment, the human sebum mimetic comprises palmitoleic acid in an amount of about 5 to about 15 wt.% of the entire mimetic composition.
In a preferred embodiment, the human sebum mimetic comprises palm itoleic acid in an amount of about 8 to about 12 wt.% of the entire mimetic composition and, in a more preferred embodiment, the human sebum mimetic comprises palmitoleic acid in an amount of about 9.7 wt.% of the entire mimetic composition. In a most preferred embodiment, the human sebum mimetic comprises the following fatty acids and fatty alcohols in weight percent:
Fatty acids: Wt. % Fatty Alcohols Wt. %
Myristic acid (14:0) 0.5 cis-11-Eicosenaol (20:1) 5.9 Palmitic acid (16:0) 4.8 cis-13-docosenol (22:1) 6.3 Palm itoleic acid (16: I ) 9.7 cis-15-tetracosenol (24:1) 1.9 Stearic acid (18:0) 1.9 Unknown 18:1 (18:1) 0.1 Oleic acid (18:1) 31.6 cis-Vaccenic acid (18:1) 1.6 Linoleic acid (18:2) 1.3 Linolenic acid (18:3) 0.1 Arachidic acid (20:0) 1.5 cis-11-Eicosenoic acid (20:1) 13.9 Behenic acid (22:0) 0.5 Erucic acid (22:1) 2.9 Lignoceric acid (24:0) 0.2 Nervonic acid (24:1) 0.3.
[0018] In another exemplary embodiment, the human sebum mimetic may comprise the compositional lipid profile of the sebum of any selected profile, such as an exemplary 22 year old human female. The human sebum mimetic may be derived from interesterifying refined jojoba oil in an amount of about 24.9 wt.% of the entire mimetic and a refined botanical oil comprising palm itolcic acid in an amount of about 61.9 wt.% of the entire mimetic. In one embodiment, the refined botanical oil comprising palmitoleic acid may comprise refined macadamia oil. The mimetic may further comprise phytosqualene in an amount of about 12.6 wt.% of the entire mimetic, phytosterols in an amount of about 0.4 wt.%
of the entire mimetic, phytosteryl macadam iatc in an amount of about 0.1 wt.% of the entire mimetic, and/or tocopherols in an amount of about 0.1 wt.%
of the entire mimetic (about 1000 parts per million).
[0019] In various embodiments of the present invention, the human sebum mimetic may further comprise an effective amount of any constituent lipid found in a stratum corneum layer of an epidermis. In one embodiment, the human sebum mimetic may comprise a derivative and/or precursor of the constituent lipid. In one embodiment, the constituent lipid may be present in the human sebum mimetic in an effective amount to organize the intercellular lamellar lipid structure of the stratum corneum to at least partially promote and/or maintain the water permeability barrier function of the skin.
For example, in one embodiment, the constituent lipid may comprise fatty acids such as long chain saturated fatty acid having chains lengths of C16 to C30 and/or unsaturated fatty acids such as linoleate. In another embodiment, the constituent lipid may comprise a sphingolipid and/or a ceramide. Sphingolipids may comprise any one or more of the structurally heterogeneous family of lipids. For example, the sphingolipids may have eighteen carbon amino-alcohol backbones that may be called sphingoid bases. In one embodiment, the mimetic may comprise the sphingolipid in an amount up to about 27 wt.% of the entire mimetic. Ceramides may comprise a structurally heterogeneous family of sphingolipid base derivatives with amide linkages to a variety of long-chain fatty acids. For example, the ceramide may comprise any one or more ceramides found in human stratum corneum, such as acylceramides. In one embodiment, the mimetic may comprise the ceramide in an amount up to about 27 wt.%
of the entire mimetic.
[0020] In various embodiments of the present invention, any human sebum mimetic may further comprise an effective amount of trace constituents of the stratum corneum layer of an epidermis. For example, in one embodiment, the trace constituent may comprise cholesterol such as cholesterol sulfate. In some embodiments, the cholesterol sulfate may be comprise a portion of a human sebum mimetic in an amount similar to the amount of cholesterol sulfate found in a stratum corneum, such as up to about 2 to about wt.% of the entire mimetic. In another embodiment, the trace constituent may be a mineral such as calcium (Ca2+). In some embodiments, the mimetic may comprise the trace constituent in an amount up to about 12 wt.% of the entire mimetic.
[0021] In another exemplary embodiment, the human sebum mimetics contemplated herein comprise additional functional additives, that is, an ingredient added to perform a particular function. For example, the human sebum mimetics may comprise tocopherols. In one embodiment, the human sebum mimetic comprises about 100 to about 2000 parts per million (ppm) of 70%
tocopherols, preferably about 1430 ppm. The human sebum mimetics may also comprise fragrances, dyes, pigments, preservatives, antioxidants, moisturizers,
7 and the like. By way of a further example, the human sebum mimetics may comprise emollients or thickeners, such as, FLORAESTERSTm 20 (FE-20) available from International Flora Technologies, Ltd. of Chandler, Arizona.
FLORAESTERSTm 20 may be used to increase the viscosity and/or the bulk melting/dropping point of the mimetic, to more closely replicate the wax ester profile of human sebum. etc.
[0022] Alternatively, or in addition, the human sebum mimetics may be used as a component in a wide range of personal care products, such as a hair care lotions, shampoos, hair conditioners, hair gels, hair oils, hair colors, hair relaxers, hand lotions, facial lotions, eye creams, facial soaps, body lotions and creams, body scrubs, shaving gels, hair removers, sanitary wipes, and the like. Because their compositions are closely analogous to that of human sebum, the human sebum mimetics may facilitate the natural healing and recovery system of the human skin and accelerate cell turn-over and topical blood circulation, thereby decreasing the appearance of wrinkles, dark circles under eyes, and age spots. The human sebum mimetics may also reduce irritation on the scalp through natural healing and improve hydration of the skin. The human sebum m imetics could also be used beyond human application and could be used on animals and to keep fruits and vegetables fresh.
[0023] The human sebum mimetics contemplated herein are particularly suitable as substitutes for lost human sebum due to their stability. Oil stability is measured according to the American Oil Chemists' Society's Official Method Cd 12b-92 at 110 C. In one embodiment, the human sebum mimetics contemplated herein have an oil stability index greater than 50 hours at I I 0 C. In this regard, the mimetics are substantially resistant to oxidation and have a shelf life that makes them desirable as, and in, personal care products.
[0024] In accordance with an exemplary embodiment, a method for producing a human sebum mimetic comprises mixing refined macadamia oil and refined jojoba oil, interesterifying the refined macadamia oil and the refined jojoba oil to produce a wax ester comprising a fatty acid having 16 carbons
FLORAESTERSTm 20 may be used to increase the viscosity and/or the bulk melting/dropping point of the mimetic, to more closely replicate the wax ester profile of human sebum. etc.
[0022] Alternatively, or in addition, the human sebum mimetics may be used as a component in a wide range of personal care products, such as a hair care lotions, shampoos, hair conditioners, hair gels, hair oils, hair colors, hair relaxers, hand lotions, facial lotions, eye creams, facial soaps, body lotions and creams, body scrubs, shaving gels, hair removers, sanitary wipes, and the like. Because their compositions are closely analogous to that of human sebum, the human sebum mimetics may facilitate the natural healing and recovery system of the human skin and accelerate cell turn-over and topical blood circulation, thereby decreasing the appearance of wrinkles, dark circles under eyes, and age spots. The human sebum mimetics may also reduce irritation on the scalp through natural healing and improve hydration of the skin. The human sebum m imetics could also be used beyond human application and could be used on animals and to keep fruits and vegetables fresh.
[0023] The human sebum mimetics contemplated herein are particularly suitable as substitutes for lost human sebum due to their stability. Oil stability is measured according to the American Oil Chemists' Society's Official Method Cd 12b-92 at 110 C. In one embodiment, the human sebum mimetics contemplated herein have an oil stability index greater than 50 hours at I I 0 C. In this regard, the mimetics are substantially resistant to oxidation and have a shelf life that makes them desirable as, and in, personal care products.
[0024] In accordance with an exemplary embodiment, a method for producing a human sebum mimetic comprises mixing refined macadamia oil and refined jojoba oil, interesterifying the refined macadamia oil and the refined jojoba oil to produce a wax ester comprising a fatty acid having 16 carbons
8 and one double bond, adding a phytosterol, and adding phytosqualene.
Phytosterol can be added to the refined macadamia oil and the refined jojoba oil before interesterification and/or after interesterification. The resulting human sebum mimetic can then be bleached and/or deodorized.
[0025] In one exemplary embodiment, a mixture of 53.2 grams (g) refined macadamia oil, 30.8 g refined jojoba oil and 2.1 g phytosterol are mixed and heated to 90 C while stirring under vacuum. After about 0.5 hours, 0.84 g sodium methoxide is added to the mixture and the temperature is increased to 130 C and maintained at that temperature for about 2 to about 2.5 hours. The mixture is then cooled to 90 C, and 0.84 g citric acid is added with stirring for 0.5 hours. The mixture is then filtered. I g phytosterol and 12.9 g phytosqualene is added to the filtrate, which is mixed until homogeneity is achieved, resulting in the mimetic. 1 wt.% bleaching earth (Clarion 470 bleaching clay available from American Colloid Company, Arlington Heights, Ill.) may be added to the mimetic, which is then heated to 95 C and maintained for 15 to 30 minutes with stirring under vacuum. The mixture is filtered. To remove odors and other volatile materials, the mimetic may be heated to 200 ¨ 220 C under high vacuum while water vapor is injected into it. The temperature is maintained for about 2 hours and then cooled while still under vacuum. In a preferred embodiment, 1430 ppm tocopherol (70%) is added and mixed into the mimetic. Any additional additives also may be added at this time.
[0026] The following are exemplary embodiments of personal care products comprising the human sebum mimetic produced as described above, with each of the components set forth in % wt/wt of the personal care product.
The examples are provided for illustration purposes only and are not meant to limit the various embodiments of the human sebum mimetic in any way.
[0027] Example 1 is a hair conditioning lotion providing multiple functions including moisturizing, shining, holding, and anti-breaking functions.
Phytosterol can be added to the refined macadamia oil and the refined jojoba oil before interesterification and/or after interesterification. The resulting human sebum mimetic can then be bleached and/or deodorized.
[0025] In one exemplary embodiment, a mixture of 53.2 grams (g) refined macadamia oil, 30.8 g refined jojoba oil and 2.1 g phytosterol are mixed and heated to 90 C while stirring under vacuum. After about 0.5 hours, 0.84 g sodium methoxide is added to the mixture and the temperature is increased to 130 C and maintained at that temperature for about 2 to about 2.5 hours. The mixture is then cooled to 90 C, and 0.84 g citric acid is added with stirring for 0.5 hours. The mixture is then filtered. I g phytosterol and 12.9 g phytosqualene is added to the filtrate, which is mixed until homogeneity is achieved, resulting in the mimetic. 1 wt.% bleaching earth (Clarion 470 bleaching clay available from American Colloid Company, Arlington Heights, Ill.) may be added to the mimetic, which is then heated to 95 C and maintained for 15 to 30 minutes with stirring under vacuum. The mixture is filtered. To remove odors and other volatile materials, the mimetic may be heated to 200 ¨ 220 C under high vacuum while water vapor is injected into it. The temperature is maintained for about 2 hours and then cooled while still under vacuum. In a preferred embodiment, 1430 ppm tocopherol (70%) is added and mixed into the mimetic. Any additional additives also may be added at this time.
[0026] The following are exemplary embodiments of personal care products comprising the human sebum mimetic produced as described above, with each of the components set forth in % wt/wt of the personal care product.
The examples are provided for illustration purposes only and are not meant to limit the various embodiments of the human sebum mimetic in any way.
[0027] Example 1 is a hair conditioning lotion providing multiple functions including moisturizing, shining, holding, and anti-breaking functions.
9 [0028] EXAMPLE 1 Ingredient wt./wt. %
Phase A Water 77.95 Polyquatem ium-3 7 0.70 Glycerin 3.00 SodiumPCA 1.00 Panthenol 0.50 Silicone Quatemium-8 2.00 Phase B Human Sebum Mimetic 3.00 Phase C Sorbitan Stearate (and) Sucrose Cocoate 2.00 PhaseD Propanediol 8.00 Quatemium 79 Hydrolyzed 0.50 Keratin Preservative 1.00 Phase E Fragrance 0.35 Total 100.00 [0029] The hair conditioning lotion of Example 1 is manufactured by heating the water to 45 C with stirring and adding the Polyquatemium 37 with medium propeller agitation. The solution is mixed until a clear gel forms. The remaining ingredients in Phase A are added to the gel in the order listed. The ingredients in Phase B are added together at 45 C. The mixture of the Phase B ingredients is then added to the ingredients of Phase A with rapid propeller agitation. The Phase A and B ingredients are heated to 60 C, and the Phase C ingredient is added with medium propeller agitation. All ingredients of Phase D are mixed at 60 C
and are added to the Phase ABC mixture with medium propeller agitation. The resulting formula is cooled quickly on an ice-water bath. The fragrance of Phase E is then added.
[0030] Example 2 is another hair conditioning lotion providing multiple functions including moisturizing, shining, holding, and anti-breaking functions.
[0031] EXAMPLE 2 Ingredient %wt/wt Phase A Water 71.95 Polyquatemi um-37 1.00 Glycerin 3.00 SodiumPCA 1.00 Panthenol 0.50 Silicone Quatemium-8 2.00 Phase B Ethyl Macadamiate (and) 2.00 Tocopherol (and) Mahe Acid Human Sebum Mimetic 3.00 Isopropyl Jojobate (and) Jojoba 1.00 Alcohol (and) Jojoba Esters Phenyltrimethicone 1.00 Phase C Sorbitan Stearate (and) 2.00 Sucrose Cocoatc PhaseD Propanediol 8.00 Jojoba Oil PEG-150 Esters 1.50 Quatemium-79 Hydrolyzed 0.50 Keratin Preservative 1.00 I lydrolyzed Jojoba Esters (and) 1.00 Jojoba Esters (and) Water Phase E Fragrance 0.35 Total 100.00 The hair conditioning lotion of Example 2 is manufactured using the same method as described above for Example I .
[0032] Accordingly, human sebum mimetics and methods for producing them have been provided. The human sebum mimetics are formed from phytosqualene, phytosterols, refined jojoba oil, and a refined botanical oil, such as macadamia oil, comprising palmitoleic acid. Of its fatty acids, human sebum has particularly high levels of palmitic acid (16:0), sapienic acid (16:1 6), and oleic acid (C18:1 9).
Analogously, the human sebum mimetics contemplated herein also comprise high levels of palmitic acid and oleic acid. In one embodiment, the human sebum mimetics comprise about 1 to about 10 wt.% palmitic acid and about 25 to about 35 wt.%
oleic acid. However, sapienic acid is unique among mammals and rarely found in nature. The inventors have found that by interesterifying the refined macadamia oil and the refined jojoba oil of' the human sebum mimetics, a wax ester comprising palm itoleic acid, a substitute for sapienic acid, results.
In one embodiment, the human sebum mimetics comprise palmitoleic acid in an amount of about 5 to about 15 wt.% of the entire mimetic composition.
[0033] While at least one exemplary embodiment has been presented in the foregoing detailed description of the invention, it should be appreciated that a vast number of variations exist. It should also be appreciated that the exemplary embodiment or exemplary embodiments are only examples, and are not intended to limit the scope, applicability, or configuration of the invention in any way. Rather, the foregoing detailed description will provide those skilled in the art with a convenient road map for implementing an exemplary embodiment of the invention. It being understood that various changes may be made in the function and arrangement of elements described in an exemplary embodiment without departing from the scope of the invention as set forth in the appended claims.
Phase A Water 77.95 Polyquatem ium-3 7 0.70 Glycerin 3.00 SodiumPCA 1.00 Panthenol 0.50 Silicone Quatemium-8 2.00 Phase B Human Sebum Mimetic 3.00 Phase C Sorbitan Stearate (and) Sucrose Cocoate 2.00 PhaseD Propanediol 8.00 Quatemium 79 Hydrolyzed 0.50 Keratin Preservative 1.00 Phase E Fragrance 0.35 Total 100.00 [0029] The hair conditioning lotion of Example 1 is manufactured by heating the water to 45 C with stirring and adding the Polyquatemium 37 with medium propeller agitation. The solution is mixed until a clear gel forms. The remaining ingredients in Phase A are added to the gel in the order listed. The ingredients in Phase B are added together at 45 C. The mixture of the Phase B ingredients is then added to the ingredients of Phase A with rapid propeller agitation. The Phase A and B ingredients are heated to 60 C, and the Phase C ingredient is added with medium propeller agitation. All ingredients of Phase D are mixed at 60 C
and are added to the Phase ABC mixture with medium propeller agitation. The resulting formula is cooled quickly on an ice-water bath. The fragrance of Phase E is then added.
[0030] Example 2 is another hair conditioning lotion providing multiple functions including moisturizing, shining, holding, and anti-breaking functions.
[0031] EXAMPLE 2 Ingredient %wt/wt Phase A Water 71.95 Polyquatemi um-37 1.00 Glycerin 3.00 SodiumPCA 1.00 Panthenol 0.50 Silicone Quatemium-8 2.00 Phase B Ethyl Macadamiate (and) 2.00 Tocopherol (and) Mahe Acid Human Sebum Mimetic 3.00 Isopropyl Jojobate (and) Jojoba 1.00 Alcohol (and) Jojoba Esters Phenyltrimethicone 1.00 Phase C Sorbitan Stearate (and) 2.00 Sucrose Cocoatc PhaseD Propanediol 8.00 Jojoba Oil PEG-150 Esters 1.50 Quatemium-79 Hydrolyzed 0.50 Keratin Preservative 1.00 I lydrolyzed Jojoba Esters (and) 1.00 Jojoba Esters (and) Water Phase E Fragrance 0.35 Total 100.00 The hair conditioning lotion of Example 2 is manufactured using the same method as described above for Example I .
[0032] Accordingly, human sebum mimetics and methods for producing them have been provided. The human sebum mimetics are formed from phytosqualene, phytosterols, refined jojoba oil, and a refined botanical oil, such as macadamia oil, comprising palmitoleic acid. Of its fatty acids, human sebum has particularly high levels of palmitic acid (16:0), sapienic acid (16:1 6), and oleic acid (C18:1 9).
Analogously, the human sebum mimetics contemplated herein also comprise high levels of palmitic acid and oleic acid. In one embodiment, the human sebum mimetics comprise about 1 to about 10 wt.% palmitic acid and about 25 to about 35 wt.%
oleic acid. However, sapienic acid is unique among mammals and rarely found in nature. The inventors have found that by interesterifying the refined macadamia oil and the refined jojoba oil of' the human sebum mimetics, a wax ester comprising palm itoleic acid, a substitute for sapienic acid, results.
In one embodiment, the human sebum mimetics comprise palmitoleic acid in an amount of about 5 to about 15 wt.% of the entire mimetic composition.
[0033] While at least one exemplary embodiment has been presented in the foregoing detailed description of the invention, it should be appreciated that a vast number of variations exist. It should also be appreciated that the exemplary embodiment or exemplary embodiments are only examples, and are not intended to limit the scope, applicability, or configuration of the invention in any way. Rather, the foregoing detailed description will provide those skilled in the art with a convenient road map for implementing an exemplary embodiment of the invention. It being understood that various changes may be made in the function and arrangement of elements described in an exemplary embodiment without departing from the scope of the invention as set forth in the appended claims.
Claims (44)
1. A human sebum mimetic composition comprising:
a wax ester derived from interesterification of:
a refined jojoba oil; and a refined botanical oil comprising palmitoleic acid;
a phytosterol;
phytosqualene;
phytosteryl macadamiate; and a constituent lipid of a stratum comeum layer of an epidermis.
a wax ester derived from interesterification of:
a refined jojoba oil; and a refined botanical oil comprising palmitoleic acid;
a phytosterol;
phytosqualene;
phytosteryl macadamiate; and a constituent lipid of a stratum comeum layer of an epidermis.
2. The human sebum mimetic composition of claim 1, wherein the refined botanical oil comprising palmitoleic acid comprises more than 10 wt.%
palmitoleic acid.
palmitoleic acid.
3. The human sebum mimetic composition of claim 1, wherein the refined botanical oil is refined macadamia oil.
4. The human sebum mimetic composition of claim 1, further comprising about to about 10 wt.% palmitic acid.
5. The human sebum mimetic composition of claim 4, comprising about 3 to about 7 wt.% palmitic acid.
6. The human sebum mimetic composition of claim 1, further comprising about to about 35 wt.% oleic acid.
7. The human sebum mimetic composition of claim 6, comprising about 30 to about 34 wt.% oleic acid.
8. The human sebum mimetic composition of claim 1, comprising about 5 to about 15 wt.% palmitoleic acid.
9. The human sebum mimetic composition of claim 8, comprising about 8 to about 12 wt.% palmitoleic acid.
10. The human sebum mimetic composition of claim 1, having an oil stability index greater than 50 hours at 110°C.
11. The human sebum mimetic composition of claim 1, wherein the constituent lipid of a stratum corneum layer of an epidermis comprises a sphingolipid.
12. The human sebum mimetic composition of claim 1, wherein the constituent lipid of a stratum corneum layer of an epidermis comprises a ceramide.
13. The human sebum mimetic composition of claim 1, wherein the constituent lipid of the stratum corneum layer of the epidermis is a trace constituent.
14. The human sebum mimetic composition of claim 13, wherein the trace constituent comprises a cholesterol.
15. The human sebum mimetic composition of claim 14, wherein the cholesterol comprises cholesterol sulfate.
16. The human sebum mimetic composition of claim 13, further comprising a mineral.
17. The human sebum mimetic composition of claim 16, wherein the mineral comprises calcium.
18. The human sebum mimetic composition of claim 1, further comprising a functional additive.
19. The human sebum mimetic composition of claim 18, wherein the functional additive is at least one of a tocopherol, a fragrance, a dye, a pigment, a preservative, an antioxidant, a moisturizer, an emollient, and a thickener.
20. Use of the human sebum mimetic composition of claim 1 in a personal care product adapted for care of human or animal skin or hair.
21. The use of claim 20, wherein the personal care product is a hair conditioning lotion.
22. A human sebum mimetic composition comprising:
a wax ester derived from interesterification of:
refined jojoba oil; and an oil comprising a triglyceride and palmitoleic acid;
a phytosterol;
phytosqualene;
phytosteryl macadamiate; and a constituent lipid of a stratum comeum layer of an epidermis.
a wax ester derived from interesterification of:
refined jojoba oil; and an oil comprising a triglyceride and palmitoleic acid;
a phytosterol;
phytosqualene;
phytosteryl macadamiate; and a constituent lipid of a stratum comeum layer of an epidermis.
23. The human sebum mimetic composition of claim 22, wherein the oil comprising the triglyceride comprises more than 10 wt.% palmitoleic acid.
24. The human sebum mimetic composition of claim 22, wherein the oil comprising the triglyceride is refined macadamia oil.
25. The human sebum mimetic composition of claim 22, further comprising about 1 to about 10 wt.% palmitic acid.
26. The human sebum mimetic composition of claim 25, wherein the palmitic acid is about 3 to about 7 wt.% of the human sebum mimetic composition.
27. The human sebum mimetic composition of claim 22, further comprising about 25 to about 35 wt.% oleic acid.
28. The human sebum mimetic composition of claim 27, wherein the oleic acid is about 30 to about 34 wt.% of the human sebum mimetic composition.
29. The human sebum mimetic composition of claim 22, wherein the palmitoleic acid is about 5 to about 15 wt.% of the human sebum mimetic composition.
30. The human sebum mimetic composition of claim 22, wherein the palmitoleic acid is about 8 to about 12 wt.% of the human sebum mimetic composition.
31. The human sebum mimetic composition of claim 22, having an oil stability index greater than 50 hours at 110°C.
32. The human sebum mimetic composition of claim 22, wherein the constituent lipid of human stratum corneum comprises a sphingolipid.
33. The human sebum mimetic composition of claim 32, wherein the sphingolipid is up to 27 wt.% of the human sebum mimetic composition.
34. The human sebum mimetic composition of claim 25, wherein the constituent lipid of human stratum corneum comprises a ceramide.
35. The human sebum mimetic composition of claim 34, wherein the ceramide is up to 27 wt.% of the human sebum mimetic composition.
36. The human sebum mimetic composition of claim 22, wherein the constituent lipid of human stratum corneum is a trace constituent.
37. The human sebum mimetic composition of claim 36, wherein the trace constituent comprises cholesterol.
38. The human sebum mimetic composition of claim 37, wherein the cholesterol comprises cholesterol sulfate.
39. The human sebum mimetic composition of claim 38, further comprising a mineral.
40. The human sebum mimetic composition of claim 39, wherein the mineral comprises calcium.
41. The human sebum mimetic composition of claim 22, further comprising a functional additive.
42. The human sebum mimetic composition of claim 41, wherein the functional additive is at least one of a tocopherol, a fragrance, a dye, a pigment, a preservative, an antioxidant, a moisturizer, an emollient, and a thickener.
43. Use of the human sebum mimetic composition of claim 22 in a personal care product adapted for care of human or animal skin or hair.
44. The use of claim 43, wherein the personal care product is a hair conditioning lotion.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261697240P | 2012-09-05 | 2012-09-05 | |
| US61/697,240 | 2012-09-05 | ||
| US13/689,501 | 2012-11-29 | ||
| US13/689,501 US8765106B2 (en) | 2009-10-26 | 2012-11-29 | Human sebum mimetics derived from botanical sources and methods for making the same |
| PCT/US2013/057791 WO2014039423A1 (en) | 2012-09-05 | 2013-09-03 | Human sebum mimetics derived from botanical sources and methods for making the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2884331A1 CA2884331A1 (en) | 2014-03-13 |
| CA2884331C true CA2884331C (en) | 2019-08-06 |
Family
ID=50237550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2884331A Active CA2884331C (en) | 2012-09-05 | 2013-09-03 | Human sebum mimetics derived from botanical sources and methods for making the same |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP2892502A4 (en) |
| JP (1) | JP2015527393A (en) |
| AU (1) | AU2013312920B2 (en) |
| CA (1) | CA2884331C (en) |
| WO (1) | WO2014039423A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6562921B2 (en) * | 2013-12-18 | 2019-08-21 | インターナショナル フローラ テクノロジーズ,リミテッド | Human sebum mimetic derived from plant sources and method for producing the same |
| KR20220148853A (en) * | 2020-02-28 | 2022-11-07 | 조이스 에이치. 마 | Formulations and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6706768B2 (en) * | 2002-03-21 | 2004-03-16 | International Flora Technologies, Ltd. | Production and use of novel alkoxylated monoesters |
| US8343468B2 (en) * | 2009-10-26 | 2013-01-01 | International Flora Technologies, Ltd. | Human sebum mimetics derived from botanical sources and methods for making the same |
-
2013
- 2013-09-03 EP EP13835599.5A patent/EP2892502A4/en not_active Ceased
- 2013-09-03 JP JP2015531141A patent/JP2015527393A/en active Pending
- 2013-09-03 CA CA2884331A patent/CA2884331C/en active Active
- 2013-09-03 AU AU2013312920A patent/AU2013312920B2/en active Active
- 2013-09-03 WO PCT/US2013/057791 patent/WO2014039423A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| CA2884331A1 (en) | 2014-03-13 |
| WO2014039423A1 (en) | 2014-03-13 |
| EP2892502A1 (en) | 2015-07-15 |
| EP2892502A4 (en) | 2015-09-02 |
| AU2013312920A1 (en) | 2015-04-16 |
| AU2013312920B2 (en) | 2018-05-24 |
| JP2015527393A (en) | 2015-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8765105B2 (en) | Human sebum mimetics derived from botanical sources and methods for making the same | |
| CN109908021A (en) | One kind aqueous lip balm product having repairing effect and preparation method thereof | |
| CN109771337A (en) | A kind of fat of Oromaius norvaehollandeae lip-stick and preparation method thereof | |
| BG1687U1 (en) | Cosmetic composition | |
| US9289373B2 (en) | Human sebum mimetics derived from botanical sources and methods for making the same | |
| CA2884331C (en) | Human sebum mimetics derived from botanical sources and methods for making the same | |
| KR20190079291A (en) | Cosmetic composition containing pseudo-ceramide originated from botanical oil | |
| US8765106B2 (en) | Human sebum mimetics derived from botanical sources and methods for making the same | |
| JP2001233754A (en) | Emulsion type skin care preparation | |
| Bhatnagar et al. | Oils and fats as raw materials for cosmetics | |
| CA2932042C (en) | Human sebum mimetics derived from botanical sources and methods for making the same | |
| JP3671103B2 (en) | Cosmetics | |
| US20150004139A1 (en) | Emollient Compounds Useful for Treating Dry Skin Conditions | |
| da Costa Sanches et al. | The use of vegetable oils to prevent skin aging | |
| EP1693050B1 (en) | Care product for skin and/or hair, and the use thereof | |
| RU2170569C1 (en) | Cosmetic cream | |
| KR20180132726A (en) | Diesters for personal care derived from 1-methylheptyl alcohol | |
| ITTO20070815A1 (en) | USE OF ALCHILOSSAZOLIDINONE AS A MOISTURIZING COSMETIC AGENT AND SKIN HYDRATION PROCEDURE | |
| RU2582293C1 (en) | Baby cosmetic stick for lips and face | |
| CN105726348B (en) | Cosmetic composition | |
| KR910003106B1 (en) | Skin cosmetics containing liposomes and sphingolipids | |
| UA80353C2 (en) | Cream with a uplift-effect |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20180316 |